CClinicalTrials.gg
CompletedNCT03384992FoRtitudeUpdated Apr 30, 2018

Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer Survivors

An interventional study of Diaphragmatic breathing and relaxation and Cognitive restructuring in Breast Cancer and Fear of Cancer, sponsored by Wake Forest University Health Sciences. Completed. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-30.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
215
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The FoRtitude trial aims to evaluate an eHealth intervention designed to teach breast cancer survivors strategies to manage anxiety about cancer recurrence. The eHealth intervention includes educational content and interactive tools, designed to teach coping strategies and/or inert content, depending on the study participant's randomization assignment. The FoRtitude study will examine whether three coping strategies (relaxation training, cognitive restructuring, worry practice) are more effective than general health-related content in reducing fear of cancer recurrence.

Read the detailed description

The purpose of the FoRtitude trial is to develop and evaluate a targeted eHealth intervention designed to teach breast cancer survivors (BCS) coping strategies to manage fear about cancer recurrence (FoR). FoRtitude, a web-based program with interactive text messaging capabilities, was created to deliver a targeted intervention for BCS with moderate to severe FoR. FoRtitude consists of didactic content presented in written and video-based formats and interactive tools, designed to teach coping strategies. Commonly used cognitive behavior therapy (CBT) techniques were tailored to the management of FoR and included diaphragmatic breathing and relaxation, cognitive restructuring, and scheduled worry practice. Participants are encouraged to use the FoRtitude site several times per week over a period of 4 weeks. The investigators employed principles of user-centered design to create the FoRtitude website and incorporated feedback from 17 BCS to refine site content and improve FoRtitude usability.

After refining the FoRtitude site, the investigators will conduct a randomized controlled trial using the Multiphase Optimization Strategy (MOST) to individually evaluate three coping strategies; each coping strategy will be compared to health management content. Inert content includes general health information and managing comorbid illnesses, information on general nutrition, and information on nutritional topics of interest to BCS. Half of the participants will be randomized to receive telecoaching, which included 3-4 telephone-based brief sessions with a motivational interviewer, aimed at improving adherence to use of the FoRtitude site. Participants will complete questionnaires at baseline, 4 weeks (immediately after completing the FoRtitude site) and at 8 weeks.

Study hypotheses:

  1. BCS randomized to Relaxation training will report a greater reduction in fear of cancer recurrence from pre-post intervention than BCS randomized to inert (health management) content
  2. BCS randomized to Cognitive restructuring will report a greater reduction in fear of cancer recurrence from pre-post intervention than BCS randomized to inert (health management) content
  3. BCS randomized to Scheduled Worry practice will report a greater reduction in fear of cancer recurrence from pre-post intervention than BCS randomized to inert (health management) content
  4. BCS randomized to receive Telecoaching will demonstrate higher adherence to using the FoRtitude site and will report a greater reduction in fear of cancer recurrence from pre-post intervention compared to BCS randomized to no Telecoaching
  5. BCS randomized to a higher number of coping strategies will report a greater reduction in fear of cancer recurrence from pre-post intervention than BCS randomized to receive all inert content or fewer coping strategies (dose-response effect)
02

Conditions studied

  • Breast Cancer
  • Fear of Cancer

Keywords

  • Fear of Cancer Recurrence
  • ehealth interventions
  • PROMIS
  • FoR
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Female
  • Diagnosis of breast cancer, non-metastatic, stage I-III
  • Completed primary treatment for breast cancer (surgery, chemotherapy and/or radiation therapy, current hormonal treatment allowable)
  • No current evidence of disease

    1. Greater than 1 year post treatment (for phase I interviews and usability testing)
    2. Between 1 and 10 years post-treatment (for Phase I field testing and Phase II)
  • Good overall functional status as evidenced by ECOG Performance Status \< 3
  • At least 18 years of age (for Phase I only)
  • At least 19 years of age (for Phase 2 only)
  • Able to speak and read English
  • Able to provide informed consent
  • Clinically significant FoR, measured by the 9-item FCRI severity scale using established cut-off

    a. Patients may be eligible for Phase I and Phase IV of the study regardless of their FCRI score

  • Cellular telephone with SMS messaging capability and access to a computer with broadband Internet access
  • Self-reported familiarity with the Internet per Internet Usage Patterns Measure
  • For Phase III, participants must have participated in Phase II
  • For Phase IV, participants must be a self-identified African American breast cancer survivor that is willing to review site content and provide feedback in addition to meeting inclusion criteria above (with exception of FCRI severity scale score)

Exclusion criteria

Exclusion Criteria:

  • Visual, hearing, voice, or motor impairment that would prevent completion of study procedures
  • Diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, or other diagnosis for which participation in this trial is either inappropriate or dangerous
  • Hazardous substance or alcohol use
  • Suicidal ideation, plan, intent
  • Dementia
  • Or if the participant is deemed ineligible by the investigators for reasons not otherwise specified.
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
215 participants (actual)

Study arms

  • Experimental
    Group 1

    Participants were exposed to the following conditions: general health for week 1, diet-general information for week 2, and diet-BCSS information (breast cancer survivor-specific) for week 3. Telephone coaching was given.

    Other: Telephone coaching · Other: Usual care

  • Experimental
    Group 2

    Participants were exposed to the one of the following usual care conditions: general health for week 1, diet-general information for week 2, and diet-BCSS information (breast cancer survivor-specific) for week 3.

    Other: Usual care

  • Experimental
    Group 3

    Participants were exposed to the following conditions: cognitive restructuring for week 1, general health for week 2, and diet-general information and diet-BCSS information (breast cancer survivor-specific) for week 3. Telephone coaching was given.

    Other: Cognitive restructuring · Other: Telephone coaching · Other: Usual care

  • Experimental
    Group 4

    Participants were exposed to the following conditions: cognitive restructuring for week 1, general health for week 2, and diet-general information and diet-BCSS information (breast cancer survivor-specific) for week 3.

    Other: Cognitive restructuring · Other: Usual care

  • Experimental
    Group 5

    Participants were exposed to the following conditions: scheduled worry practice for week 1, general health for week 2, and diet-general information and diet-BCSS information (breast cancer survivor-specific) for week 3. Telephone coaching was given.

    Other: Scheduled worry practice · Other: Telephone coaching · Other: Usual care

  • Experimental
    Group 6

    Participants were exposed to the following conditions: scheduled worry practice for week 1, general health for week 2, and diet-general information and diet-BCSS information (breast cancer survivor-specific) for week 3.

    Other: Scheduled worry practice · Other: Usual care

  • Experimental
    Group 7

    Participants were exposed to the following conditions: cognitive restructuring for week 1, worry practice for week 2, and General Health and Diet (General and BCSS) for week 3. Telephone coaching was given.

    Other: Cognitive restructuring · Other: Scheduled worry practice · Other: Telephone coaching · Other: Usual care

  • Experimental
    Group 8

    Participants were exposed to the following conditions: cognitive restructuring for week 1, scheduled worry practice for week 2, and General Health and Diet (General and BCSS) for week 3.

    Other: Cognitive restructuring · Other: Scheduled worry practice · Other: Usual care

  • Experimental
    Group 9

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, general health for week 2, and Diet - General and BCSS for week 3. Telephone coaching was given.

    Other: Diaphragmatic breathing and relaxation · Other: Telephone coaching · Other: Usual care

  • Experimental
    Group 10

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, general health for week 2, and Diet - General and BCSS for week 3.

    Other: Diaphragmatic breathing and relaxation · Other: Usual care

  • Experimental
    Group 11

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, cognitive restructuring for week 2, and General health and Diet (General and BCSS) for week 3. Telephone coaching was given.

    Other: Diaphragmatic breathing and relaxation · Other: Cognitive restructuring · Other: Telephone coaching · Other: Usual care

  • Experimental
    Group 12

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, cognitive restructuring for week 2, and General health and Diet (General and BCSS) for week 3.

    Other: Diaphragmatic breathing and relaxation · Other: Cognitive restructuring · Other: Usual care

  • Experimental
    Group 13

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, worry practice for week 2, and General health and Diet (General and BCSS) for week 3. Telephone coaching was given.

    Other: Diaphragmatic breathing and relaxation · Other: Scheduled worry practice · Other: Telephone coaching · Other: Usual care

  • Experimental
    Group 14

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, scheduled worry practice for week 2, and General health and Diet (General and BCSS) for week 3.

    Other: Diaphragmatic breathing and relaxation · Other: Scheduled worry practice · Other: Usual care

  • Experimental
    Group 15

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, worry practice for week 2, and cognitive restructuring for week 3. Telephone coaching was given.

    Other: Diaphragmatic breathing and relaxation · Other: Cognitive restructuring · Other: Scheduled worry practice · Other: Telephone coaching

  • Experimental
    Group 16

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, scheduled worry practice for week 2, and cognitive restructuring for week 3.

    Other: Diaphragmatic breathing and relaxation · Other: Cognitive restructuring · Other: Scheduled worry practice

Interventions

  • OtherDiaphragmatic breathing and relaxation

    Education on physiological effects of anxiety, instructions in diaphragmatic breathing and relaxation techniques, and audio-recordings 5-15 minutes in length that provide guided relaxation exercises (autogenic, imagery-based and progressive muscle relaxation).

  • OtherCognitive restructuring

    Education on the thought-emotion connection and exercises designed to better understand cognitions associated with increased anxiety and tools to evaluate and replace anxiety-generating cognitions. Includes an interactive tool (thought record) participants complete to facilitate this process.

  • OtherScheduled worry practice

    Education on the association between avoidance and increased anxiety, and instructions on actively thinking about feared events to reduce avoidance and engage healthy coping strategies. Interactive tool includes a video-based guided worry practice session and an interactive worksheet and timer.

  • OtherTelephone coaching

    BCS will receive 5 TeleCoaching calls over a period of 4 weeks, to include one introductory phone call, followed by 4 calls focused each week on the current CSM; if the participant is not randomized to a CSM, TeleCoaching will provide reflective listening and encouragement.

  • OtherUsual care

    Includes general health, diet-general information and diet-BCSS (breast cancer survivor-specific) information.

05

What researchers measure

Primary outcomes

  1. Fear of Cancer Recurrence Inventory (FCRI) total score (minus Coping and Reassurance subscales)

    Questionnaire aims to better understand the experience of worries about cancer recurrence. Scaled from 1-4 with 4 being "all the time" and 1 being "never". The FCRI is the only FoR measure validated using interview to define 'caseness' and has demonstrated reliability and validity with English speaking survivors. FCRI total score to be calculated without including the Coping and Reassurance subscales defined a priori and determined by FoR theoretical model.

    Time frame: Baseline to Week 8 change score

Secondary outcomes

  1. Impact of Events Scale - Revised

    Questionnaire to assess illness-related distress and post-truamatic type anxiety

    Time frame: Baseline to Week 8 change score

  2. Concerns about Recurrence Scale (CARS) - 4 item severity score

    Questionnaire to assess concerns about recurrence among BCS

    Time frame: Baseline to Week 8 change score

  3. PROMIS Anxiety Computer adaptive test

    Questions administered using a computer adaptive test-based algorithm to assess overall anxiety

    Time frame: Baseline to Week 8 change score

  4. PROMIS Depression Computer adaptive test

    Questions administered using a computer adaptive test-based algorithm to assess depression

    Time frame: Baseline to Week 8 change score

  5. PROMIS Sleep Disturbance Computer adaptive test

    Questions administered using a computer adaptive test-based algorithm to assess sleep disturbances

    Time frame: Baseline to Week 8 change score

  6. PROMIS Fatigue Computer adaptive test

    Questions administered using a computer adaptive test-based algorithm to assess fatigue

    Time frame: Baseline to Week 8 change score

  7. PROMIS Global Health

    Questionnaire to assess overall health and health-related quality of life

    Time frame: Baseline to Week 8 change score

  8. PROMIS Applied Cognition Computer adaptive test

    Questions administered using a computer adaptive test-based algorithm to assess patient-reported cognitive impairments

    Time frame: Baseline to Week 8 change score

  9. Breast Cancer Self-Efficacy scale (BCSE)

    Questionnaire to assess confidence in one's ability to manage breast cancer

    Time frame: Baseline to Week 8 change score

06

Study locations

No study locations are listed for this record.

07

Registry details

Key details

Study ID
NCT03384992
Lead sponsor
Wake Forest University Health Sciences
Collaborators
National Cancer Institute (NCI)
Responsible party
Sponsor
First posted
Dec 28, 2017
Start date
Mar 2014
Primary completion
Dec 5, 2015
Completion
Dec 5, 2015
Last update
Apr 30, 2018

Study contacts

Lynne Wagner, Ph.D.
principal investigator · Wake Forest University Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion